All articles tagged with #shinya yamanaka
Kyoto University’s CiRA defends Nobel Prize winner Shinya Yamanaka amid Gotham City Research’s allegations of image duplication across about 10 papers. Some cases had prior investigations with corrections or no evidence of duplication, and CiRA says there are no known ongoing institutional probes, while several items involve coauthors or materials sharing rather than misconduct.
Japan approved two therapies derived from reprogrammed human iPS cells for heart failure and Parkinson’s disease, marking the first global use of iPS-derived cells in approved medical products. The treatments—one applied to the heart surface and the other injected into the brain—entered conditional, time-limited use requiring ongoing safety and effectiveness data after launch, reflecting Japan’s specialized regulatory and manufacturing infrastructure and the ongoing influence of Shinya Yamanaka in the field.